Java Development Kit (JDK) 26, a planned update to standard Java due March 17, 2026, has reached its second release candidate (RC) stage. The RC is open for critical bug fixes, with the feature set ...

From the browser to the back end, the ‘boring’ choice is exciting again. We look at three trends converging to bring SQL back ...

Smithsonian Associates Hosts an Evening With Paul Hollywood, "New York Times" Best-Selling Author and Star of "The Great British Baking Show" ...

Safe coding is a collection of software design practices and patterns that allow for cost-effectively achieving a high degree ...

The 2025-2026 tuition rate is $1,254 per unit. Please click "Tuition and Fees" above for full details and cost of attendance. In addition to our standard requirements, you must also submit your ...

TIOBE Index for February 2026: Top 10 Most Popular Programming Languages Your email has been sent February’s TIOBE Index shows a leaderboard that looks steady at first glance, but small shifts beneath ...

Examine the MCA 2026 syllabus: a thorough overview of the essential subjects, broken down by semester, and highlighting popular specializations like artificial intelligence and cloud computing in ...

CLEVELAND, Ohio – Wintertime activities don’t slow down in Greater Cleveland, and we’ve got a diverse list of things to do. Several concerts and comedy shows are on tap, as are basketball and hockey ...

Veronica Beagle is the managing editor for Education at Forbes Advisor. She completed her master’s in English at the University of Hawai‘i at Mānoa. Before coming to Forbes Advisor she worked on ...

Warper 7.2 is a cutting-edge open-source React virtualization library utilizing Rust and WebAssembly for unmatched performance. With zero-allocation hot paths and O(1) circular buffer operations, ...

Just like algae blooms in the ocean and pollen in the spring, there’s been an explosion in the past year or two of new software, related tools and lingo from the IT and mainstream/consumer side. Some ...

Enliven Therapeutics Inc. (Nasdaq: ELVN) reported this week that as of the end of 2025, the clinical-stage precision oncology company has $462.6 million in cash and equivalents, enough runway to fund ...